| Autor: |
Theodorakis MJ; Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom., Coleman RL; Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom., Feng H; Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom., Chan J; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong., Chiasson JL; Department of Medicine, University of Montreal, CRCHUM, Montreal, Canada., Ge J; Zhongshan Hospital, Fudan University, Shanghai, China., Gerstein HC; Department of Medicine and Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada., Huo Y; Department of Cardiology, Peking University First Hospital, Beijing, China., Lang Z; Bayer Pharmaceuticals China, Beijing, China., McMurray JJ; Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Rydén L; Cardiology Unit, Karolinska University Hospital Solna, Stockholm, Sweden., Schröder S; Bayer AG, Pharma Division, Berlin, Germany., Tendera M; Department of Cardiology and Structural Heart Diseases, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland., Tuomilehto J; Department of Neurosciences and Preventive Medicine, Danube-University Krems, Krems, Austria; Chronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland; King Abdulaziz University, Jeddah, Saudi Arabia; Dasman Diabetes Institute, Dasman, Kuwait., Yang W; China-Japan Friendship Hospital, Beijing, China., Hu D; People's Hospital of Peking University, Beijing, China., Pan C; Department of Endocrinology, People's Liberation Army General Hospital, Beijing, China., Holman RR; Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom. Electronic address: rury.holman@dtu.ox.ac.uk. |
Full Text from ScienceDirect